The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...

Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

Marc Filippino Like really big tariffs. Donald Trump voice clip If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they’re gonna be tariffed at a ...